| A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article I Sharifi, MR Aflatoonian, AR Fekri, MH Parizi, AA Afshar, A Khosravi, ... Iranian journal of public health 44 (3), 299, 2015 | 89 | 2015 |
| Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran M Bamorovat, I Sharifi, MR Aflatoonian, H Sharifi, A Karamoozian, ... PloS one 13 (2), e0192236, 2018 | 73 | 2018 |
| A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran MR Aflatoonian, I Sharifi, M Hakimi Parizi, AR Fekri, B Aflatoonian, ... PloS one 9 (2), e89043, 2014 | 48 | 2014 |
| Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects M Mostafavi, I Sharifi, S Farajzadeh, P Khazaeli, H Sharifi, E Pourseyedi, ... Biomedicine & Pharmacotherapy 116, 108942, 2019 | 42 | 2019 |
| Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran MR Aflatoonian, I Sharifi, B Aflatoonian, M Bamorovat, A Heshmatkhah, ... PLoS neglected tropical diseases 13 (6), e0007423, 2019 | 42 | 2019 |
| The present status of cutaneous leishmaniasis in a recently emerged focus in south-west of Kerman Province, Iran A Khosravi, I Sharifi, E Dortaj, AA Afshar, M Mostafavi Iranian Journal of Public Health 42 (2), 182, 2013 | 38 | 2013 |
| The prevalence of pre-hypertension and hypertension in an Iranian urban population A Khosravi, MH Emamian, M Shariati, H Hashemi, A Fotouhi High blood pressure & cardiovascular prevention 21, 127-135, 2014 | 36 | 2014 |
| Prevalence of Trypanosoma evansi in camels using molecular and parasitological methods in the southeast of Iran, 2011 A Khosravi, M Hakimi Parizi, M Bamorovat, M Borhani Zarandi, ... Journal of Parasitic Diseases 39, 422-425, 2015 | 35 | 2015 |
| Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis M Bamorovat, I Sharifi, MA Mohammadi, S Eybpoosh, S Nasibi, ... Microbial pathogenesis 116, 124-129, 2018 | 34 | 2018 |
| Clinical Features of Anthroponotic Cutaneous Leishmaniasis in a Major Focus, Southeastern Iran, 1994–2014 AK Ahmad Khosravi, Ahmad KHOSRAVI 1 , *Iraj SHARIFI 1 , Alireza FEKRI 1 ... Iranian Journal of Parasitology 12 (4), 544, 2017 | 30 | 2017 |
| Effectiveness of two H9N2 low pathogenic avian influenza conventional inactivated oil emulsion vaccines on H9N2 viral replication and shedding in broiler chickens H Tavakkoli, K Asasi, A Mohammadi Iranian Journal of Veterinary Research 12 (3), 214-221, 2011 | 30 | 2011 |
| Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 … M Bamorovat, I Sharifi, MR Aflatoonian, B Sadeghi, A Shafiian, RT Oliaee, ... International immunopharmacology 69, 321-327, 2019 | 28 | 2019 |
| Embryonic toxico-pathological effects of meglumine antimoniate using a chick embryo model A Khosravi, I Sharifi, H Tavakkoli, A Derakhshanfar, AR Keyhani, Z Salari, ... PLoS One 13 (5), e0196424, 2018 | 28 | 2018 |
| Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to Leishmania tropica M Bamorovat, I Sharifi, R Tavakoli Oliaee, A Jafarzadeh, A Khosravi Frontiers in Microbiology 12, 638957, 2021 | 20 | 2021 |
| Anti-leishmanial effect of nanosilver solutions on Leishmania tropica promastigotes by in-vitro assay A Khosravi, I Sharifi, M Barati, M Zarean, M Hakimi-Parizi Zahedan Journal of Research in Medical Sciences 13 (7), 2011 | 19 | 2011 |
| Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment M Bamorovat, I Sharifi, MR Aflatoonian, A Karamoozian, A Tahmouresi, ... International Journal of Infectious Diseases 122, 155-161, 2022 | 16 | 2022 |
| In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and … A Keyhani, I Sharifi, E Salarkia, A Khosravi, RT Oliaee, Z Babaei, ... International Immunopharmacology 101, 108274, 2021 | 16 | 2021 |
| A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models M Bamorovat, I Sharifi, A Fekri, A Keyhani, MR Aflatoonian, ... Microbial pathogenesis 128, 162-170, 2019 | 16 | 2019 |
| The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling RT Oliaee, I Sharifi, M Bamorovat, A Keyhani, Z Babaei, E Salarkia, ... International Immunopharmacology 86, 106704, 2020 | 14 | 2020 |
| Toxico-pathological effects of meglumine antimoniate on human umbilical vein endothelial cells A Khosravi, I Sharifi, H Tavakkoli, AR Keyhani, A Afgar, Z Salari, ... Toxicology in Vitro 56, 10-18, 2019 | 12 | 2019 |
Iraj SharifiLeishmania Research Center, Kerman University of Medical Sciences, Kerman, IranVerified email at kmu.ac.ir
